Edition:
United Kingdom

Suven Life Sciences Ltd (SUVP.NS)

SUVP.NS on National Stock Exchange of India

192.15INR
23 May 2018
Change (% chg)

Rs3.60 (+1.91%)
Prev Close
Rs188.55
Open
Rs189.35
Day's High
Rs194.75
Day's Low
Rs188.25
Volume
1,010,656
Avg. Vol
574,568
52-wk High
Rs250.80
52-wk Low
Rs155.00

Select another date:

Tue, Feb 20 2018

BRIEF-Suven Life Sciences ‍Secures Product Patents In India And South Korea​

* PATENTS CORRESPONDING TO NEW CHEMICAL ENTITIES FOR TREATMENT OF DISORDERS RELATED TO NEURODEGENERATIVE DISEASES Source text: http://bit.ly/2sDvu6P Further company coverage:

BRIEF-Suven Life Sciences Secures Product Patents In Aripo, South Korea

* SUVEN LIFE SCIENCES - PATENTS FOR NCES FOR TREATING DISORDERS ASSOCIATED WITH NEURODEGENERATIVE DISEASES; PATENTS VALID THROUGH 2033 AND 2034 Source text - http://bit.ly/2nnkGoi Further company coverage:

BRIEF-India's Suven Life Sciences Dec-Qtr Net Profit Rises

* DEC QUARTER NET PROFIT 346 MILLION RUPEES VERSUS PROFIT 242.7 MILLION RUPEES YEAR AGO

BRIEF-Suven Life Sciences Secures Product Patents In Canada, India

* SAYS PATENT CORRESPONDING TO NEW CHEMICAL ENTITIES (NCES) FOR TREATMENT OF DISORDERS ASSOCIATED WITH NEURODEGENERATIVE DISEASES

BRIEF-Suven Life Sciences Gets Product Patents In India, U.S.

* SAYS CO SECURES PRODUCT PATENTS IN INDIA AND USA Source text - http://bit.ly/2AtbqHG Further company coverage:

BRIEF-India's Suven Life Sciences Secures Product Patents In Eurasia, Norway

* PATENTS CORRESPONDS TO NEW CHEMICAL ENTITIES (NCES) FOR TREATMENT OF DISORDERS ASSOCIATED WITH NEURODEGENERATIVE DISEASES Source text - http://bit.ly/2AUMl7N Further company coverage:

Select another date: